CD19 CAR mRNA (Mouse)

Cat. No.: HY-153084: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

CD19 CAR mRNA (Mouse) will express mouse CD19 CAR protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 CAR is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.

For research use only. We do not sell to patients.

CD19 CAR mRNA (Mouse) Chemical Structure

Size	Price	Stock	Quantity
Solvent
500 μg（2 mg/mL * 250 μL in Water）	USD 1000	In-stock	Estimated Time of Arrival: December 31

Synthetic products have potential research and development risk.

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of CD19 CAR mRNA (Mouse):

CD19 CAR mRNA (Human) Get quote

1 Publications Citing Use of MCE CD19 CAR mRNA (Mouse)

•bioRxiv. 2024 September 08.

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	CD19 CAR mRNA (Mouse) will express mouse CD19 CAR protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 CAR is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.
Appearance	Liquid
Color	Colorless to light yellow
SMILES	[CD19 CAR mRNA (Mouse)]
Shipping	Shipping with dry ice.
Storage	-80°C
Purity & Documentation	Select Batch: Data Sheet (264 KB) SDS (251 KB) COA (242 KB) Handling Instructions (2659 KB)
References	[1]. Boissel L, Betancur M, Wels WS, Tuncer H, Klingemann H. Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells. Leuk Res. 2009;33(9):1255-1259. [Content Brief]